Phase II Study of RAD001 Head and Neck Cancer

NCT01051791 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Everolimus 10mg daily

Sponsor

Julie E. Bauman, MD, MPH

Collaborators

[object Object]